Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker? (Q38021707)

27 August 2017

title

Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker? (English)

1 reference

acute decompensated heart failure

27 August 2017

0 references

0 references

1 reference

Mihael Potocki

1

1 reference

27 August 2017

Ronny Ziller

series ordinal

2

1 reference

27 August 2017

Christian Mueller

series ordinal

3

1 reference

27 August 2017

publication date

1 September 2012

1 reference

Current heart failure reports

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

244-251

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Plasma adrenomedullin concentration in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Short-term mortality risk in emergency department acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin and its related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Vasopressor activities of N-terminal fragments of adrenomedullin in anesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Cell and molecular biology of the multifunctional peptide, adrenomedullin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Regulation of adrenomedullin secretion from cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Cardioprotective effect of adrenomedullin in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Immunohistochemical localization of somatostatin receptor SST2A in the rat pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Endogenous adrenomedullin protects against vascular response to injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-I, natriuretic peptides and noradrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-012-0096-6

Adrenomedullin is upregulated in the heart and aorta during the early and late stages of sepsis

21 January 2018

1 reference

12 December 2020

Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of rats

1 reference

12 December 2020

Mechanisms of adrenomedullin-induced vasodilation in the rat kidney

1 reference

12 December 2020

Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue

1 reference

12 December 2020

Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells

1 reference

12 December 2020

Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure

1 reference

12 December 2020

Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin

1 reference

12 December 2020

Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure

1 reference

12 December 2020

Increased plasma levels of adrenomedullin in patients with heart failure

1 reference

12 December 2020

Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure

1 reference

12 December 2020

Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage

1 reference

12 December 2020

Shear stress augments expression of C-type natriuretic peptide and adrenomedullin

1 reference

12 December 2020

The small intestine is an important source of adrenomedullin release during polymicrobial sepsis.

1 reference

12 December 2020

Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers

1 reference

12 December 2020

Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat

1 reference

12 December 2020

Cardiac production and secretion of adrenomedullin are increased in heart failure

1 reference

12 December 2020

Benchmarks for the assessment of novel cardiovascular biomarkers

1 reference

12 December 2020

Endothelial cells actively synthesize and secrete adrenomedullin

1 reference

12 December 2020

Adrenomedullin, a multifunctional regulatory peptide

1 reference

12 December 2020

Adrenomedullin in experimental congestive heart failure: cardiorenal activation

1 reference

12 December 2020

Secretion of proadrenomedullin N-terminal 20 peptide from cultured neonatal rat cardiac cells

1 reference

12 December 2020

Adrenomedullin: a hypotensive hormone in man

1 reference

12 December 2020

Elevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure

1 reference

12 December 2020

Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension

1 reference

12 December 2020

Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)

1 reference

12 December 2020

10.1007/S11897-012-0096-6

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1014359071

0 references

1 reference